Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Evident Technologies Biotin Activated Quantum Dots

July 8th, 2004

Evident Technologies Biotin Activated Quantum Dots

Abstract:
Evident Technologies, Inc. announced today that it has begun commercial production of its first biotinylated
quantum dot fluorophores. The Biotin EviFluor(R) is available in wavelengths from blue to near infrared. The unique quantum dot EviFluor(R) offers significant advantages over traditional fluorophores, and can enable next
generation applications in cell biology, drug discovery, cancer research and many other fields.

Source:
PRNewswire

Bookmark:

Related News Press

Products

International survey supports need for built-in water protection on smartphones and tablets May 21st, 2013

Peratech designs the QTC Ultra Sensor - an ultra-sensitive touch sensor for domestic, commercial and industrial use: Pressure sensor so sensitive that it can be operated through glass or steel sheet May 13th, 2013

Industrial Nanotech Launches Nansulate(R) Vinyl Fresh: Clear Liquid Thermal Insulation and UV Protection Coating Rejuvenates Vinyl Siding on Homes April 18th, 2013

MouthWatchers Nano-Silver Tooth Brush Released for Sale April 12th, 2013

Nanomedicine

UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013

Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013

How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013

MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013